APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polycaprolactone

Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C. It is most commonly used in the production of specialty polyurethanes, imparting excellent resistance to water, oil, solvents, and chlorine. Chemically, it consists of the repeating unit (C₆H₁₀O₂)ₙ, with the systematic IUPAC name poly(hexano-6-lactone) and CAS registry number 24980-41-4. Typical physical properties include a density of 1.145 g/cm³ and thermal conductivity of 0.05 W/(m·K) at 25 °C. PCL undergoes biodegradation through hydrolysis of its ester bonds under physiological conditions and is degradable by microorganisms from the Bacillota and Pseudomonadota phyla. It has received FDA approval for select human applications such as drug delivery devices, sutures, and adhesion barriers.

Polycaprolactone is synthesized primarily by ring-opening polymerization of ε-caprolactone, catalyzed most often by stannous octoate in the presence of low-molecular-weight alcohols as chain-length modifiers. This process enables precise control of molecular weight, yielding products ranging from low-molecular-weight polyols to high-molecular-weight resins. In industrial applications, PCL functions as a specialty polyol for thermoplastic polyurethane elastomers, coatings, adhesives, sealants, and cast elastomers, delivering superior low-temperature flexibility, hydrolytic stability, low melt viscosity, and light stability. In biomedical fields, it serves as a bioabsorbable polymer for long-term implants, controlled-release drug systems, tissue engineering scaffolds, bone repair composites, dental materials, and dermal fillers, with tunable intrinsic viscosity, degradation profiles spanning months to years, and customizable end groups.

Additional uses include resin additives to improve processability and impact resistance, blends with starch for enhanced biodegradability and cost efficiency, polymeric plasticizers for polyvinyl chloride, and filaments for fused deposition modeling 3D printing. Polycaprolactone combines outstanding biocompatibility, complete biodegradability to carbon dioxide and water, and excellent processability through low melt viscosity and good solubility. Its performance can be tailored via molecular weight, copolymer ratios, and end-group chemistry to satisfy GMP-grade and FDA requirements, positioning it as a foundational material for high-performance industrial polyurethanes and advanced biomedical technologies.

Composition, supplied form and processing history determine the usable material. Evaluate the property required by the actual application with the specified test method; a chemistry name alone does not define a finished grade.

What turns activity into demand

Qualified formulation or component output creates material purchases through loading, process yield and the supplied mass basis. Raw material, formulated blend and finished-part revenues describe separate transaction stages.

The commercial boundary

For Polycaprolactone, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable polycaprolactone performance?

Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C. Match formulation and impurity limits to the converting process, then verify the property after processing or curing. Compare like-for-like dry or as-supplied quantities; a finished component and its raw material represent different transaction stages.

Selected research

Market Outlook & Growth Opportunities

Global Polycaprolactone Market Outlook and Growth Opportunities 2026

27 February 2026197 pages

Choose your research edition.

Industry ResearchPolycaprolactone Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Polycaprolactone Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Polycaprolactone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polycaprolactone Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Polycaprolactone Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C. It is most commonly used in the production of specialty polyurethanes, imparting excellent resistance to water, oil, solvents, and chlorine. Chemically, it consists of the repeating unit (C₆H₁₀O₂)ₙ, with the systematic IUPAC name poly(hexano-6-lactone) and CAS registry number 24980-41-4. Typical physical properties include a density of 1.145 g/cm³ and thermal conductivity of 0.05 W/(m·K) at 25 °C. PCL undergoes biodegradation through hydrolysis of its ester bonds under physiological conditions and is degradable by microorganisms from the Bacillota and Pseudomonadota phyla. It has received FDA approval for select human applications such as drug delivery devices, sutures, and adhesion barriers.

Polycaprolactone is synthesized primarily by ring-opening polymerization of ε-caprolactone, catalyzed most often by stannous octoate in the presence of low-molecular-weight alcohols as chain-length modifiers. This process enables precise control of molecular weight, yielding products ranging from low-molecular-weight polyols to high-molecular-weight resins. In industrial applications, PCL functions as a specialty polyol for thermoplastic polyurethane elastomers, coatings, adhesives, sealants, and cast elastomers, delivering superior low-temperature flexibility, hydrolytic stability, low melt viscosity, and light stability. In biomedical fields, it serves as a bioabsorbable polymer for long-term implants, controlled-release drug systems, tissue engineering scaffolds, bone repair composites, dental materials, and dermal fillers, with tunable intrinsic viscosity, degradation profiles spanning months to years, and customizable end groups.

Additional uses include resin additives to improve processability and impact resistance, blends with starch for enhanced biodegradability and cost efficiency, polymeric plasticizers for polyvinyl chloride, and filaments for fused deposition modeling 3D printing. Polycaprolactone combines outstanding biocompatibility, complete biodegradability to carbon dioxide and water, and excellent processability through low melt viscosity and good solubility. Its performance can be tailored via molecular weight, copolymer ratios, and end-group chemistry to satisfy GMP-grade and FDA requirements, positioning it as a foundational material for high-performance industrial polyurethanes and advanced biomedical technologies.

Read the full market overview

The global Polycaprolactone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Polycaprolactone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Polycaprolactone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Polycaprolactone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Polycaprolactone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Polycaprolactone market include Ingevity, Daicel, BASF, Hunan Juren Chemical, Corbion, Seqens International and Shenzhen Esun Industrial, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Polycaprolactone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polycaprolactone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polycaprolactone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polycaprolactone market size, projected growth trends, production technologies, key applications, and end-use industries.

Polycaprolactone Segment by Company

Ingevity

Daicel

BASF

Hunan Juren Chemical

Corbion

Seqens International

Shenzhen Esun Industrial

Polycaprolactone Segment by Type

Double Functional Caprolactone

Tri Functional Caprolactone

High Molar Mass PCL Polymers

Others

Polycaprolactone Segment by Application

Resins & Coatings

Elastomers

Adhesives

Medical Devices

Others

Polycaprolactone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Polycaprolactone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Polycaprolactone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Polycaprolactone significant trends, drivers, influence factors in global and regions.

6. To analyze Polycaprolactone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polycaprolactone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polycaprolactone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polycaprolactone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polycaprolactone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polycaprolactone industry.

Chapter 3: Detailed analysis of Polycaprolactone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Polycaprolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Polycaprolactone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Polycaprolactone Industry Trends Table 2. Polycaprolactone Industry Drivers Table 3. Polycaprolactone Industry Opportunities and Challenges Table 4. Polycaprolactone Industry Restraints Table 5. Global Polycaprolactone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Polycaprolactone Revenue Share by Company (2021-2026) Table 7. Global Polycaprolactone Sales Volume by Company (t) & (2021-2026) Table 8. Global Polycaprolactone Sales Volume Share by Company (2021-2026) Table 9. Global Polycaprolactone Average Price (USD/t) of Company (2021-2026) Table 10. Global Polycaprolactone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Polycaprolactone Key Company Manufacturing Base & Headquarters Table 12. Global Polycaprolactone Company, Product Type & Application Table 13. Global Polycaprolactone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Polycaprolactone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Double Functional Caprolactone Table 18. Significant Companies of Tri Functional Caprolactone Table 19. Significant Companies of High Molar Mass PCL Polymers Table 20. Significant Companies of Others Table 21. Global Polycaprolactone Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Polycaprolactone Sales Volume by Type (2021-2026) & (t) Table 23. Global Polycaprolactone Sales Volume by Type (2027-2032) & (t) Table 24. Global Polycaprolactone Sales Volume Share by Type (2021-2026) Table 25. Global Polycaprolactone Sales Volume Share by Type (2027-2032) Table 26. Global Polycaprolactone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Polycaprolactone Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Polycaprolactone Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Polycaprolactone Sales Value Share by Type (2021-2026) Table 30. Global Polycaprolactone Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Resins & Coatings Table 32. Significant Companies of Elastomers Table 33. Significant Companies of Adhesives Table 34. Significant Companies of Medical Devices Table 35. Significant Companies of Others Table 36. Global Polycaprolactone Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 37. Global Polycaprolactone Sales Volume by Application (2021-2026) & (t) Table 38. Global Polycaprolactone Sales Volume by Application (2027-2032) & (t) Table 39. Global Polycaprolactone Sales Volume Share by Application (2021-2026) Table 40. Global Polycaprolactone Sales Volume Share by Application (2027-2032) Table 41. Global Polycaprolactone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Polycaprolactone Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Polycaprolactone Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Polycaprolactone Sales Value Share by Application (2021-2026) Table 45. Global Polycaprolactone Sales Value Share by Application (2027-2032) Table 46. Global Polycaprolactone Sales by Region: 2021 VS 2025 VS 2032 (t) Table 47. Global Polycaprolactone Sales by Region (2021-2026) & (t) Table 48. Global Polycaprolactone Sales Market Share by Region (2021-2026) Table 49. Global Polycaprolactone Sales by Region (2027-2032) & (t) Table 50. Global Polycaprolactone Sales Market Share by Region (2027-2032) Table 51. Global Polycaprolactone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Polycaprolactone Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Polycaprolactone Sales Value Share by Region (2021-2026) Table 54. Global Polycaprolactone Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Polycaprolactone Sales Value Share by Region (2027-2032) Table 56. Global Polycaprolactone Market Average Price (USD/t) by Region (2021-2026) Table 57. Global Polycaprolactone Market Average Price (USD/t) by Region (2027-2032) Table 58. Global Polycaprolactone Sales by Country: 2021 VS 2025 VS 2032 (t) Table 59. Global Polycaprolactone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Polycaprolactone Sales by Country (2021-2026) & (t) Table 61. Global Polycaprolactone Sales Market Share by Country (2021-2026) Table 62. Global Polycaprolactone Sales by Country (2027-2032) & (t) Table 63. Global Polycaprolactone Sales Market Share by Country (2027-2032) Table 64. Global Polycaprolactone Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Polycaprolactone Sales Value Market Share by Country (2021-2026) Table 66. Global Polycaprolactone Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Polycaprolactone Sales Value Market Share by Country (2027-2032) Table 68. Ingevity Company Information Table 69. Ingevity Business Overview Table 70. Ingevity Polycaprolactone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. Ingevity Polycaprolactone Product Portfolio Table 72. Ingevity Recent Development Table 73. Daicel Company Information Table 74. Daicel Business Overview Table 75. Daicel Polycaprolactone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Daicel Polycaprolactone Product Portfolio Table 77. Daicel Recent Development Table 78. BASF Company Information Table 79. BASF Business Overview Table 80. BASF Polycaprolactone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. BASF Polycaprolactone Product Portfolio Table 82. BASF Recent Development Table 83. Hunan Juren Chemical Company Information Table 84. Hunan Juren Chemical Business Overview Table 85. Hunan Juren Chemical Polycaprolactone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Hunan Juren Chemical Polycaprolactone Product Portfolio Table 87. Hunan Juren Chemical Recent Development Table 88. Corbion Company Information Table 89. Corbion Business Overview Table 90. Corbion Polycaprolactone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Corbion Polycaprolactone Product Portfolio Table 92. Corbion Recent Development Table 93. Seqens International Company Information Table 94. Seqens International Business Overview Table 95. Seqens International Polycaprolactone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Seqens International Polycaprolactone Product Portfolio Table 97. Seqens International Recent Development Table 98. Shenzhen Esun Industrial Company Information Table 99. Shenzhen Esun Industrial Business Overview Table 100. Shenzhen Esun Industrial Polycaprolactone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Shenzhen Esun Industrial Polycaprolactone Product Portfolio Table 102. Shenzhen Esun Industrial Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Polycaprolactone Distributors List Table 106. Polycaprolactone Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Polycaprolactone Product Image Figure 2. Global Polycaprolactone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polycaprolactone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Polycaprolactone Sales (2021-2032) & (t) Figure 5. Global Polycaprolactone Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Polycaprolactone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Double Functional Caprolactone Image Figure 10. Tri Functional Caprolactone Image Figure 11. High Molar Mass PCL Polymers Image Figure 12. Others Image Figure 13. Global Polycaprolactone Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Polycaprolactone Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Polycaprolactone Sales Volume Share by Type (2021-2032) Figure 16. Global Polycaprolactone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Polycaprolactone Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Polycaprolactone Sales Value Share by Type (2021-2032) Figure 19. Resins & Coatings Image Figure 20. Elastomers Image Figure 21. Adhesives Image Figure 22. Medical Devices Image Figure 23. Others Image Figure 24. Global Polycaprolactone Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 25. Global Polycaprolactone Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Polycaprolactone Sales Volume Share by Application (2021-2032) Figure 27. Global Polycaprolactone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Polycaprolactone Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Polycaprolactone Sales Value Share by Application (2021-2032) Figure 30. Global Polycaprolactone Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 31. Global Polycaprolactone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Polycaprolactone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Polycaprolactone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Polycaprolactone Sales Value (2021-2032) & (US$ Million) Figure 35. North America Polycaprolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Polycaprolactone Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Polycaprolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Polycaprolactone Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Polycaprolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Polycaprolactone Sales Value (2021-2032) & (US$ Million) Figure 41. South America Polycaprolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Polycaprolactone Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Polycaprolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Polycaprolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Polycaprolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Polycaprolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Polycaprolactone Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Polycaprolactone Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Double Functional Caprolactone
  • Tri Functional Caprolactone
  • High Molar Mass PCL Polymers
  • Others
Applications
  • Resins & Coatings
  • Elastomers
  • Adhesives
  • Medical Devices
  • Others
Companies covered
  • Ingevity
  • Daicel
  • BASF
  • Hunan Juren Chemical
  • Corbion
  • Seqens International
  • Shenzhen Esun Industrial

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Polycaprolactone Sales Value (2021-2032)
  4. 1.2.2 Global Polycaprolactone Sales Volume (2021-2032)
  5. 1.2.3 Global Polycaprolactone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Polycaprolactone Market Dynamics
  1. 2.1 Polycaprolactone Industry Trends
  2. 2.2 Polycaprolactone Industry Drivers
  3. 2.3 Polycaprolactone Industry Opportunities and Challenges
  4. 2.4 Polycaprolactone Industry Restraints
3 Polycaprolactone Market by Company
  1. 3.1 Global Polycaprolactone Company Revenue Ranking in 2025
  2. 3.2 Global Polycaprolactone Revenue by Company (2021-2026)
  3. 3.3 Global Polycaprolactone Sales Volume by Company (2021-2026)
  4. 3.4 Global Polycaprolactone Average Price by Company (2021-2026)
  5. 3.5 Global Polycaprolactone Company Ranking (2024-2026)
  6. 3.6 Global Polycaprolactone Company Manufacturing Base and Headquarters
  7. 3.7 Global Polycaprolactone Company Product Type and Application
  8. 3.8 Global Polycaprolactone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Polycaprolactone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Polycaprolactone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Polycaprolactone Market by Type
  1. 4.1 Polycaprolactone Type Introduction
  2. 4.1.1 Double Functional Caprolactone
  3. 4.1.2 Tri Functional Caprolactone
  4. 4.1.3 High Molar Mass PCL Polymers
  5. 4.1.4 Others
  6. 4.2 Global Polycaprolactone Sales Volume by Type
  7. 4.2.1 Global Polycaprolactone Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Polycaprolactone Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Polycaprolactone Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Polycaprolactone Sales Value by Type
  11. 4.3.1 Global Polycaprolactone Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Polycaprolactone Sales Value by Type (2021-2032)
  13. 4.3.3 Global Polycaprolactone Sales Value Share by Type (2021-2032)
5 Polycaprolactone Market by Application
  1. 5.1 Polycaprolactone Application Introduction
  2. 5.1.1 Resins & Coatings
  3. 5.1.2 Elastomers
  4. 5.1.3 Adhesives
  5. 5.1.4 Medical Devices
  6. 5.1.5 Others
  7. 5.2 Global Polycaprolactone Sales Volume by Application
  8. 5.2.1 Global Polycaprolactone Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Polycaprolactone Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Polycaprolactone Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Polycaprolactone Sales Value by Application
  12. 5.3.1 Global Polycaprolactone Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Polycaprolactone Sales Value by Application (2021-2032)
  14. 5.3.3 Global Polycaprolactone Sales Value Share by Application (2021-2032)
6 Polycaprolactone Regional Sales and Value Analysis
  1. 6.1 Global Polycaprolactone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polycaprolactone Sales by Region (2021-2032)
  3. 6.2.1 Global Polycaprolactone Sales by Region: 2021-2026
  4. 6.2.2 Global Polycaprolactone Sales by Region (2027-2032)
  5. 6.3 Global Polycaprolactone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Polycaprolactone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Polycaprolactone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Polycaprolactone Sales Value by Region (2027-2032)
  9. 6.5 Global Polycaprolactone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Polycaprolactone Sales Value (2021-2032)
  12. 6.6.2 North America Polycaprolactone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Polycaprolactone Sales Value (2021-2032)
  15. 6.7.2 Europe Polycaprolactone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Polycaprolactone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Polycaprolactone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Polycaprolactone Sales Value (2021-2032)
  21. 6.9.2 South America Polycaprolactone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Polycaprolactone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Polycaprolactone Sales Value Share by Country, 2025 VS 2032
7 Polycaprolactone Country-level Sales and Value Analysis
  1. 7.1 Global Polycaprolactone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Polycaprolactone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Polycaprolactone Sales by Country (2021-2032)
  4. 7.3.1 Global Polycaprolactone Sales by Country (2021-2026)
  5. 7.3.2 Global Polycaprolactone Sales by Country (2027-2032)
  6. 7.4 Global Polycaprolactone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Polycaprolactone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Polycaprolactone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Polycaprolactone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Polycaprolactone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Polycaprolactone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Polycaprolactone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Polycaprolactone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Polycaprolactone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Polycaprolactone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Polycaprolactone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Polycaprolactone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Polycaprolactone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Polycaprolactone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Polycaprolactone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Polycaprolactone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Polycaprolactone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Polycaprolactone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Polycaprolactone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Polycaprolactone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Polycaprolactone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Polycaprolactone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Polycaprolactone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Polycaprolactone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Polycaprolactone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Polycaprolactone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Polycaprolactone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Polycaprolactone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Polycaprolactone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Polycaprolactone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Polycaprolactone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Polycaprolactone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Polycaprolactone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Polycaprolactone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ingevity
  2. 8.1.1 Ingevity Company Information
  3. 8.1.2 Ingevity Business Overview
  4. 8.1.3 Ingevity Polycaprolactone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ingevity Polycaprolactone Product Portfolio
  6. 8.1.5 Ingevity Recent Developments
  7. 8.2 Daicel
  8. 8.2.1 Daicel Company Information
  9. 8.2.2 Daicel Business Overview
  10. 8.2.3 Daicel Polycaprolactone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Daicel Polycaprolactone Product Portfolio
  12. 8.2.5 Daicel Recent Developments
  13. 8.3 BASF
  14. 8.3.1 BASF Company Information
  15. 8.3.2 BASF Business Overview
  16. 8.3.3 BASF Polycaprolactone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BASF Polycaprolactone Product Portfolio
  18. 8.3.5 BASF Recent Developments
  19. 8.4 Hunan Juren Chemical
  20. 8.4.1 Hunan Juren Chemical Company Information
  21. 8.4.2 Hunan Juren Chemical Business Overview
  22. 8.4.3 Hunan Juren Chemical Polycaprolactone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Juren Chemical Polycaprolactone Product Portfolio
  24. 8.4.5 Hunan Juren Chemical Recent Developments
  25. 8.5 Corbion
  26. 8.5.1 Corbion Company Information
  27. 8.5.2 Corbion Business Overview
  28. 8.5.3 Corbion Polycaprolactone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Corbion Polycaprolactone Product Portfolio
  30. 8.5.5 Corbion Recent Developments
  31. 8.6 Seqens International
  32. 8.6.1 Seqens International Company Information
  33. 8.6.2 Seqens International Business Overview
  34. 8.6.3 Seqens International Polycaprolactone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Seqens International Polycaprolactone Product Portfolio
  36. 8.6.5 Seqens International Recent Developments
  37. 8.7 Shenzhen Esun Industrial
  38. 8.7.1 Shenzhen Esun Industrial Company Information
  39. 8.7.2 Shenzhen Esun Industrial Business Overview
  40. 8.7.3 Shenzhen Esun Industrial Polycaprolactone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shenzhen Esun Industrial Polycaprolactone Product Portfolio
  42. 8.7.5 Shenzhen Esun Industrial Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Polycaprolactone Value Chain Analysis
  2. 9.1.1 Polycaprolactone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Polycaprolactone Sales Mode & Process
  6. 9.2 Polycaprolactone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Polycaprolactone Distributors
  9. 9.2.3 Polycaprolactone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst